Treatment availability and financial obstacles to adherence in bronchial asthma and COPD sufferers in low-resource settings


You can view the original post here
  • Soriano, J. B. et al. Prevalence and attributable well being burden of continual respiratory ailments, 1990-2017: a scientific evaluation for the International Burden of Illness Examine 2017. Lancet Respir. Med. 8, 585–596 (2020).

    Article  Google Scholar 

  • Beran, D., Zar, H. J., Perrin, C., Menezes, A. M. & Burney, P. Burden of bronchial asthma and continual obstructive pulmonary illness and entry to important medicines in low-income and middle-income nations. Lancet Respir. Med. 3, 159–170 (2015).

    Article  Google Scholar 

  • Brakema, E. A. et al. FRESH AIR collaborators. The socioeconomic burden of continual lung illness in low-resource settings throughout the globe - an observational FRESH AIR examine. Respir. Res. 20, 291 (2019).

    Article  Google Scholar 

  • Sullivan, P. W. et al. Measuring the price of poor bronchial asthma management and exacerbations. J. Bronchial asthma 54, 24–31 (2017).

    Article  Google Scholar 

  • Lee, L. Ok., Obi, E., Paknis, B., Kavati, A. & Chipps, B. Bronchial asthma management and illness burden in sufferers with bronchial asthma and allergic comorbidities. J. Bronchial asthma 55, 208–219 (2018).

    Article  Google Scholar 

  • Singh, D. et al. International Technique for the Prognosis, Administration, and Prevention of Continual Obstructive Lung Illness: the GOLD science committee report 2019. Eur. Respir. J. 53, 1900164 (2019).

    CAS  Article  Google Scholar 

  • Tabyshova, A. et al. Gaps in COPD Tips of Low- and Center-Earnings Nations: A Systematic Scoping Overview. Chest 159, 575–84 (2021).

    Article  Google Scholar 

  • WHO Mannequin Checklist of Important Medicines (twenty first record). https://apps.who.int/iris/bitstream/handle/10665/325771/WHO-MVP-EMP-IAU-2019.06-eng.pdf (2019).

  • Bazargani, Y. T., de Boer, A., Leufkens, H. G. M. & Mantel-Teeuwisse, A. Ok. Important medicines for COPD and bronchial asthma in low and middle-income nations. Thorax 69, 1149–51 (2014).

    Article  Google Scholar 

  • Bissell, Ok., Perrin, C. & Beran, D. Entry to important medicines to deal with continual respiratory illness in low-income nations. Int J. Tuberc. Lung Dis. 20, 717–728 (2016).

    CAS  Article  Google Scholar 

  • Babar, Z. U., Lessing, C., Mace, C. & Bissell, Ok. The supply, pricing and affordability of three important bronchial asthma medicines in 52 low- and middle-income nations. Pharmacoeconomics 31, 1063–1082 (2013).

    Article  Google Scholar 

  • Kibirige, D. et al. Entry to reasonably priced medicines and diagnostic checks for bronchial asthma and COPD in sub Saharan Africa: the Ugandan perspective. BMC Pulm. Med. 17, 179 (2017).

    Article  Google Scholar 

  • Usmani, O. S. et al. Essential inhaler errors in bronchial asthma and COPD: a scientific assessment of affect on well being outcomes. Respir. Res. 19, 10 (2018).

    Article  Google Scholar 

  • Mäkelä, M. J., Backer, V., Hedegaard, M. & Larsson, Ok. Adherence to inhaled therapies, well being outcomes and prices in sufferers with bronchial asthma and COPD. Respir. Med. 107, 1481–1490 (2013).

    Article  Google Scholar 

  • Laba, T. L. et al. Price-related underuse of medicines for asthma-opportunities for bettering adherence. J. Allergy Clin. Immunol. Pr. 7, 2298–2306 (2019).

    Article  Google Scholar 

  • Plaza, V. et al. Validation of the ‘Test of the Adherence to Inhalers’ (TAI) for bronchial asthma and COPD sufferers. J. Aerosol Med. Pulm. Drug Deliv. 29, 142–152 (2016).

    Article  Google Scholar 

  • World Well being Group. Adherence to long-term therapies: proof for motion. https://apps.who.int/iris/handle/10665/42682 (2003).

  • Peduzzi, P., Concato, J., Kemper, E., Holford, T. R. & Feinstein, A. R. A simulation examine of the variety of occasions per variable in logistic regression evaluation. J. Clin. Epidemiol. 49, 1373–1379 (1996).

    CAS  Article  Google Scholar 

  • Bursac, Z., Gauss, C. H., Williams, D. Ok. & Hosmer, D. W. Purposeful choice of variables in logistic regression. Supply Code Biol. Med. 3, 17 (2008).

    Article  Google Scholar 

  • Zurdinova, A. et al. Scientific justification of rational pharmacotherapy within the improvement and implementation of scientific pointers primarily based on the ideas of proof medication. Dissertation. UDC 615.084:001:616-071:616(02) (2018).

  • Tabyshova, A. et al. Medical traits, therapy patterns and financial burden of COPD in Kyrgyzstan: a FRESH AIR examine. Int. J. Chron. Impede. Pulmon. Dis. 16, 2833–2843 (2021).

    Article  Google Scholar 

  • Klijn, S. L. et al. Effectiveness and success elements of instructional inhaler approach interventions in bronchial asthma & COPD sufferers: a scientific assessment. NPJ Prim. Care Respir. Med. 27, 24 (2017).

    Article  Google Scholar 

  • Ahn, J. H. et al. The consequences of repeated inhaler gadget dealing with training in COPD sufferers: a potential cohort examine. Sci. Rep. 10, 19676 (2020).

    CAS  Article  Google Scholar 

  • Takemura, M. et al. Relationships between repeated instruction on inhalation remedy, medicine adherence, and well being standing in continual obstructive pulmonary illness. Int J. Chron. Impede. Pulmon. Dis. 6, 97–104 (2011).

    Article  Google Scholar 

  • Plaza, V. et al. Variations in adherence and non-adherence behaviour patterns to inhaler units between COPD and bronchial asthma sufferers. COPD: J. Continual Obstr. Pulm. Dis. 13, 547–554 (2016).

    Article  Google Scholar 

  • Vestbo, J. et al. Adherence to inhaled remedy, mortality and hospital admission in COPD. Thorax 64, 939–943 (2009).

    CAS  Article  Google Scholar 

  • Ágh, T., Inotai, A. & Mészáros, Á. Elements related to medicine adherence in sufferers with continual obstructive pulmonary illness. Respiration 82, 328–334 (2011).

    Article  Google Scholar 

  • Darbà, J., Ramírez, G., Sicras, A., Francoli, P. & Torvinen, S. Sánchez-de la Rosa, R. The significance of inhaler units: the selection of inhaler gadget could result in suboptimal adherence in COPD sufferers. Int J. Chron. Impede. Pulmon. Dis. 10, 2335–2345 (2015).

    Article  Google Scholar 

  • Elander, A. G. M. Inhaler approach and self-reported adherence to medicines amongst hospitalised folks with bronchial asthma and COPD. Medication Actual. World Outcomes 7, 317–23 (2020).

    Article  Google Scholar 

  • López-Campos, J. L., Quintana Gallego, E. & Carrasco Hernández, L. Standing of and techniques for bettering adherence to COPD therapy. Int. J. Chron. Impede. Pulmon. Dis. 14, 1503–15 (2019).

    Article  Google Scholar 

  • Corden, Z. M., Bosley, C. M., Rees, P. J. & Cochrane, G. M. Residence nebulized remedy for sufferers with COPD: affected person compliance with therapy and its relation to high quality of life. Chest 112, 1278–1282 (1997).

    CAS  Article  Google Scholar 

  • Krigsman, Ok., Moen, J., Nilsson, J. L. & Ring, L. Refill adherence by the aged for bronchial asthma/continual obstructive pulmonary illness medication allotted over a 10-year interval. J. Clin. Pharm. Ther. 32, 603–611 (2007).

    CAS  Article  Google Scholar 

  • Apter, A. J., Reisine, S. T., Affleck, G., Barrows, E. & ZuWallack, R. L. Adherence with twice-daily dosing of inhaled steroids. Socioeconomic and health-belief variations. Am. J. Respir. Crit. Care Med. 157, 1810–1817 (1998).

    CAS  Article  Google Scholar 

  • Duarte-de-Araújo, A., Teixeira, P., Hespanhol, V. & Correia-de-Sousa, J. COPD: understanding sufferers’ adherence to inhaled medicines. Int J. Chron. Impede. Pulmon. Dis. 13, 2767–73 (2018).

    Article  Google Scholar 

  • Claxton, A. J., Cramer, J. & Pierce, C. A scientific assessment of the associations between dose regimens and drugs compliance. Clin. Ther. 23, 1296–310 (2001).

    CAS  Article  Google Scholar 

  • van de Hei, S. J., Dierick, B. J. H., Aarts, J. E. P., Kocks, J. W. H. & van Boven, J. F. M. Customized medicine adherence administration in bronchial asthma and continual obstructive pulmonary illness: a assessment of efficient interventions and improvement of a sensible adherence toolkit. J. Allergy Clin. Immunol. Pract. 9, 3979–3994 (2021).

    Article  Google Scholar 

  • Jansen, E. M. et al. International burden of medicine non-adherence in continual obstructive pulmonary illness (COPD) and bronchial asthma: a story assessment of the scientific and financial case for sensible inhalers. J. Thorac. Dis. 13, 3846–3864 (2021).

    Article  Google Scholar 



  • You can view the original post here Show Original: https://librareview.com/treatment-availability-and-financial-obstacles-to-adherence-in-bronchial-asthma-and-copd-sufferers-in-low-resource-settings/

    Comments

    Popular posts from this blog

    How Anti-Aging Treatment Products Work

    Anti-Aging Treatments – Treatment of Age Spots

    Meat Free Taco Recipes from Dietitians